Microglia-like cell line containing TREM2 mutant gene, mouse model and construction method thereof
A technology of microglia and mutated genes, applied in the field of genetic engineering, can solve problems such as the difficulty of in-depth exploration of the role of TREM2
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0029] Materials: skin tissue cells containing the TREM2 mutant gene whose nucleotide sequence is shown in the sequence table SEQ ID No.1, and skin tissue cells containing the normal TREM2 gene.
[0030] Such as figure 1 As shown, this embodiment provides a method for constructing a microglia-like cell line containing a TREM2 mutant gene, including the following steps.
[0031] S1: Epidermal cells are induced to differentiate into pluripotent stem cells (induced pluripotent stem cells, hereinafter referred to as iPSCs)
[0032] The skin tissue cells containing the nucleotide sequence such as the TREM2 mutant gene shown in the sequence table SEQ ID No.1, and the skin tissue cells containing the normal TREM2 gene were respectively included in four transcription factors Oct4, Klf4, Sox2 and c-Myc Cells with pluripotency similar to the biological characteristics of embryonic stem cells are induced, namely iPSCs.
[0033] S2: iPSC differentiated into early primitive hematopoietic...
Embodiment 2
[0045] This embodiment provides a method for constructing a mouse model containing a TREM2 mutant gene, including the following steps.
[0046] S1: Preparation of sgRNA
[0047] 1. Design and synthesis of sgRNA: Using mouse TREM2 genome information, design and synthesize gRNA single-stranded sequences used in the CRISPR system.
[0048] TREM2 gRNA2 F: TAGG TGCACAAGGTCCCCTCCGGC (SEQ ID No. 3).
[0049] TREM2 gRNA2 R: AAAC GCCGGAGGGGACCTTGTGCA (SEQ ID No. 4).
[0050] 2. Annealing and renaturation of single-stranded oligonucleotides.
[0051] 3. Construction of pUC57-sgRNA plasmid, including the following steps: 1) Ligation of pUC gRNA plasmid, adding water to 20 μL, incubating at 37°C for 2 hours, shaking occasionally. 2) Purify the digested product with a PCR purification kit. 3) Ligate the annealed oligomers with bsai-digested pUC57-sgRNA. 4) Transformation and plating on Kan+ plates (50 g / mL). 5) M13-47 primer was sequenced to confirm that the sgRNA oligomer was insert...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 

